BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16943393)

  • 1. The application of fluorescence lifetime readouts in high-throughput screening.
    Moger J; Gribbon P; Sewing A; Winlove CP
    J Biomol Screen; 2006 Oct; 11(7):765-72. PubMed ID: 16943393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format.
    Klumpp M; Boettcher A; Becker D; Meder G; Blank J; Leder L; Forstner M; Ottl J; Mayr LM
    J Biomol Screen; 2006 Sep; 11(6):617-33. PubMed ID: 16760365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of fluorescence polarization in HTS assays.
    Huang X; Aulabaugh A
    Methods Mol Biol; 2009; 565():127-43. PubMed ID: 19551360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional optical detection based on pH dependent fluorescence lifetime.
    Gannot I; Ron I; Hekmat F; Chernomordik V; Gandjbakhche A
    Lasers Surg Med; 2004; 35(5):342-8. PubMed ID: 15611954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurements.
    Marks BD; Qadir N; Eliason HC; Shekhani MS; Doering K; Vogel KW
    Assay Drug Dev Technol; 2005 Dec; 3(6):613-22. PubMed ID: 16438657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
    Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
    Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instrument response standard in time-resolved fluorescence.
    Luchowski R; Gryczynski Z; Sarkar P; Borejdo J; Szabelski M; Kapusta P; Gryczynski I
    Rev Sci Instrum; 2009 Mar; 80(3):033109. PubMed ID: 19334909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo resolution of multiexponential decays of multiple near-infrared molecular probes by fluorescence lifetime-gated whole-body time-resolved diffuse optical imaging.
    Akers W; Lesage F; Holten D; Achilefu S
    Mol Imaging; 2007; 6(4):237-46. PubMed ID: 17711779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization.
    Müller J; Schust J; Berg T
    Anal Biochem; 2008 Apr; 375(2):249-54. PubMed ID: 18258175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process validation and screen reproducibility in high-throughput screening.
    Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
    J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors.
    Hubert CL; Sherling SE; Johnston PA; Stancato LF
    J Biomol Screen; 2003 Aug; 8(4):399-409. PubMed ID: 14567792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards metabolic mapping of the human retina.
    Schweitzer D; Schenke S; Hammer M; Schweitzer F; Jentsch S; Birckner E; Becker W; Bergmann A
    Microsc Res Tech; 2007 May; 70(5):410-9. PubMed ID: 17393496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of fluorescence polarization and time resolved fluorescence resonance energy transfer assay formats for SAR studies: Src kinase as a model system.
    Newman M; Josiah S
    J Biomol Screen; 2004 Sep; 9(6):525-32. PubMed ID: 15452339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase.
    Turek-Etienne TC; Small EC; Soh SC; Xin TA; Gaitonde PV; Barrabee EB; Hart RF; Bryant RW
    J Biomol Screen; 2003 Apr; 8(2):176-84. PubMed ID: 12844438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening scheme based on measurement of fluorescence lifetime in the nanosecond domain.
    Hoefelschweiger BK; Pfeifer L; Wolfbeis OS
    J Biomol Screen; 2005 Oct; 10(7):687-94. PubMed ID: 16129780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of membrane potential-sensitive fluorescent probes and their use in ion channel screening assays.
    Wolff C; Fuks B; Chatelain P
    J Biomol Screen; 2003 Oct; 8(5):533-43. PubMed ID: 14567780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a fluorescence-based enzyme assay of human 5-lipoxygenase.
    Pufahl RA; Kasten TP; Hills R; Gierse JK; Reitz BA; Weinberg RA; Masferrer JL
    Anal Biochem; 2007 May; 364(2):204-12. PubMed ID: 17376394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-photon lifetime imaging of fluorescent probes in intact blood vessels: a window to sub-cellular structural information and binding status.
    Douma K; Megens RT; Reitsma S; Prinzen L; Slaaf DW; Van Zandvoort MA
    Microsc Res Tech; 2007 May; 70(5):467-75. PubMed ID: 17393531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AB-plot assisted determination of fluorophore mixtures in a fluorescence lifetime microscope using spectra or quenchers.
    Hanley QS; Clayton AH
    J Microsc; 2005 Apr; 218(Pt 1):62-7. PubMed ID: 15817064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
    Harris A; Cox S; Burns D; Norey C
    J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.